Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Can Peanut Allergy Be Changed in Infancy? DBV’s THRIVE Trial Tests a Bold New Approach

FDA Agreement Clears Regulatory Path for Viaskin Peanut Patch

Lycia’s Experimental Therapy Introduces a New Way to Treat Food Allergies

Spanish Biotech Reports Encouraging Early Results for Innovative Peanut Allergy Treatment

DBV Launches Peanut Patch Study in Infants as Young as Six Months

Recap: Four Auto-Injectors on the Horizon

Promising OIT Results from UNC Phase II Trial

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

Epinephrine Auto-injectors: Where is the Long Promised Generic?

Adamis Auto-Injector Rejected by FDA

Delivering the Next Generation Auto-Injector

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

Nestlé Partners with DBV to Develop Milk Allergy Test

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...

FDA Provides Primer on Current State of Allergy Immunotherapies

Follow Us

Your School On Our Map

Put Your School on the Map